Doxofylline for Pediatric Asthma Steps 1-4. Pediatric Asthma: New Role for an Old Drug
The panoply of anti-asthma drugs for children between 6 and 18 years is not limited to those reported in the guidelines. In this review, we will re-assess the role of doxofylline, a xanthine characterized by a much higher handling than that of theophylline, as add-on treatment in pediatric asthma gr...
Saved in:
Main Authors: | Vincenzo Fierro (Author), Anna Lucia Piscitelli (Author), Edda Battaglia (Author), Alessandro Fiocchi (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Drugs for Pediatric Asthma
by: Marco Maglione, et al.
Published: (2019) -
Severe Asthma and Allergy: A Pediatric Perspective
by: Stefania Arasi, et al.
Published: (2019) -
Doxofylline: Another drug causing fixed drug eruption
by: Subramanian Kumudhini, et al.
Published: (2018) -
Do not forget asthma comorbidities in pediatric severe asthma!
by: Lucia Ronco, et al.
Published: (2022) -
New Model of Care: Pediatric Asthma Management
by: Simone Chinnis, et al.
Published: (2022)